IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

L. Vuitton, P. Marteau, W. J. Sandborn, B. G. Levesque, B. Feagan, S. Vermeire, S. Danese, G. D'Haens, M. Lowenberg, R. Khanna, G. Fiorino, S. Travis, J. Y. Mary, L. Peyrin-Biroulet

Research output: Contribution to journalArticle

Abstract

Background Crohn's disease (CD) is a chronic disabling and progressive IBD. Only strategies looking beyond symptoms and based on tight monitoring of objective signs of inflammation such as mucosal lesions may have the potential for disease modification. Endoscopic evaluation is currently the gold standard to assess mucosal lesions and has become a major therapeutic endpoint in clinical trials. Several endoscopic indices have been proposed to evaluate disease activity; unvalidated and arbitrary definitions have been used in clinical trials for defining endoscopic response and endoscopic remission in CD. Methods In these recommendations from the International Organization for the Study of Inflammatory Bowel Disease, we first reviewed all technical aspects of available endoscopic scoring systems in the literature. Second, in order to achieve consensus on endoscopic definitions of remission and response in trials, a two-round vote based on a Delphi method was performed among 14 specialists in the field of IBDs. Results At the end of the voting process, the investigators ranked first a >50% decrease in Simple Endoscopic Score for Crohn's Disease (SES-CD) or Crohn's Disease Endoscopic Index of Severity for the definition of endoscopic response, and an SES-CD 0-2 for the definition of endoscopic remission in CD. All experts agreed on a Rutgeerts' score i0-i1 for the definition of endoscopic remission after surgery.

Original languageEnglish
JournalGut
DOIs
Publication statusAccepted/In press - Sep 9 2015

Fingerprint

Crohn Disease
Clinical Trials
Politics
Inflammatory Bowel Diseases
Research Personnel
Organizations
Inflammation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Vuitton, L., Marteau, P., Sandborn, W. J., Levesque, B. G., Feagan, B., Vermeire, S., ... Peyrin-Biroulet, L. (Accepted/In press). IOIBD technical review on endoscopic indices for Crohn's disease clinical trials. Gut. https://doi.org/10.1136/gutjnl-2015-309903

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials. / Vuitton, L.; Marteau, P.; Sandborn, W. J.; Levesque, B. G.; Feagan, B.; Vermeire, S.; Danese, S.; D'Haens, G.; Lowenberg, M.; Khanna, R.; Fiorino, G.; Travis, S.; Mary, J. Y.; Peyrin-Biroulet, L.

In: Gut, 09.09.2015.

Research output: Contribution to journalArticle

Vuitton, L, Marteau, P, Sandborn, WJ, Levesque, BG, Feagan, B, Vermeire, S, Danese, S, D'Haens, G, Lowenberg, M, Khanna, R, Fiorino, G, Travis, S, Mary, JY & Peyrin-Biroulet, L 2015, 'IOIBD technical review on endoscopic indices for Crohn's disease clinical trials', Gut. https://doi.org/10.1136/gutjnl-2015-309903
Vuitton L, Marteau P, Sandborn WJ, Levesque BG, Feagan B, Vermeire S et al. IOIBD technical review on endoscopic indices for Crohn's disease clinical trials. Gut. 2015 Sep 9. https://doi.org/10.1136/gutjnl-2015-309903
Vuitton, L. ; Marteau, P. ; Sandborn, W. J. ; Levesque, B. G. ; Feagan, B. ; Vermeire, S. ; Danese, S. ; D'Haens, G. ; Lowenberg, M. ; Khanna, R. ; Fiorino, G. ; Travis, S. ; Mary, J. Y. ; Peyrin-Biroulet, L. / IOIBD technical review on endoscopic indices for Crohn's disease clinical trials. In: Gut. 2015.
@article{da0ba7aaa0d44d91aa87173c43fb88da,
title = "IOIBD technical review on endoscopic indices for Crohn's disease clinical trials",
abstract = "Background Crohn's disease (CD) is a chronic disabling and progressive IBD. Only strategies looking beyond symptoms and based on tight monitoring of objective signs of inflammation such as mucosal lesions may have the potential for disease modification. Endoscopic evaluation is currently the gold standard to assess mucosal lesions and has become a major therapeutic endpoint in clinical trials. Several endoscopic indices have been proposed to evaluate disease activity; unvalidated and arbitrary definitions have been used in clinical trials for defining endoscopic response and endoscopic remission in CD. Methods In these recommendations from the International Organization for the Study of Inflammatory Bowel Disease, we first reviewed all technical aspects of available endoscopic scoring systems in the literature. Second, in order to achieve consensus on endoscopic definitions of remission and response in trials, a two-round vote based on a Delphi method was performed among 14 specialists in the field of IBDs. Results At the end of the voting process, the investigators ranked first a >50{\%} decrease in Simple Endoscopic Score for Crohn's Disease (SES-CD) or Crohn's Disease Endoscopic Index of Severity for the definition of endoscopic response, and an SES-CD 0-2 for the definition of endoscopic remission in CD. All experts agreed on a Rutgeerts' score i0-i1 for the definition of endoscopic remission after surgery.",
author = "L. Vuitton and P. Marteau and Sandborn, {W. J.} and Levesque, {B. G.} and B. Feagan and S. Vermeire and S. Danese and G. D'Haens and M. Lowenberg and R. Khanna and G. Fiorino and S. Travis and Mary, {J. Y.} and L. Peyrin-Biroulet",
year = "2015",
month = "9",
day = "9",
doi = "10.1136/gutjnl-2015-309903",
language = "English",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

AU - Vuitton, L.

AU - Marteau, P.

AU - Sandborn, W. J.

AU - Levesque, B. G.

AU - Feagan, B.

AU - Vermeire, S.

AU - Danese, S.

AU - D'Haens, G.

AU - Lowenberg, M.

AU - Khanna, R.

AU - Fiorino, G.

AU - Travis, S.

AU - Mary, J. Y.

AU - Peyrin-Biroulet, L.

PY - 2015/9/9

Y1 - 2015/9/9

N2 - Background Crohn's disease (CD) is a chronic disabling and progressive IBD. Only strategies looking beyond symptoms and based on tight monitoring of objective signs of inflammation such as mucosal lesions may have the potential for disease modification. Endoscopic evaluation is currently the gold standard to assess mucosal lesions and has become a major therapeutic endpoint in clinical trials. Several endoscopic indices have been proposed to evaluate disease activity; unvalidated and arbitrary definitions have been used in clinical trials for defining endoscopic response and endoscopic remission in CD. Methods In these recommendations from the International Organization for the Study of Inflammatory Bowel Disease, we first reviewed all technical aspects of available endoscopic scoring systems in the literature. Second, in order to achieve consensus on endoscopic definitions of remission and response in trials, a two-round vote based on a Delphi method was performed among 14 specialists in the field of IBDs. Results At the end of the voting process, the investigators ranked first a >50% decrease in Simple Endoscopic Score for Crohn's Disease (SES-CD) or Crohn's Disease Endoscopic Index of Severity for the definition of endoscopic response, and an SES-CD 0-2 for the definition of endoscopic remission in CD. All experts agreed on a Rutgeerts' score i0-i1 for the definition of endoscopic remission after surgery.

AB - Background Crohn's disease (CD) is a chronic disabling and progressive IBD. Only strategies looking beyond symptoms and based on tight monitoring of objective signs of inflammation such as mucosal lesions may have the potential for disease modification. Endoscopic evaluation is currently the gold standard to assess mucosal lesions and has become a major therapeutic endpoint in clinical trials. Several endoscopic indices have been proposed to evaluate disease activity; unvalidated and arbitrary definitions have been used in clinical trials for defining endoscopic response and endoscopic remission in CD. Methods In these recommendations from the International Organization for the Study of Inflammatory Bowel Disease, we first reviewed all technical aspects of available endoscopic scoring systems in the literature. Second, in order to achieve consensus on endoscopic definitions of remission and response in trials, a two-round vote based on a Delphi method was performed among 14 specialists in the field of IBDs. Results At the end of the voting process, the investigators ranked first a >50% decrease in Simple Endoscopic Score for Crohn's Disease (SES-CD) or Crohn's Disease Endoscopic Index of Severity for the definition of endoscopic response, and an SES-CD 0-2 for the definition of endoscopic remission in CD. All experts agreed on a Rutgeerts' score i0-i1 for the definition of endoscopic remission after surgery.

UR - http://www.scopus.com/inward/record.url?scp=84941730242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941730242&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2015-309903

DO - 10.1136/gutjnl-2015-309903

M3 - Article

AN - SCOPUS:84941730242

JO - Gut

JF - Gut

SN - 0017-5749

ER -